FIELD: organic technology; pharmacology. SUBSTANCE: derivative of ergoline having formula I wherein R1-C2H5,R2-(CH2)3N(CH3)2,, R3 is allyl, R4=R5=H is prepared by interaction of ergoline amide having formula II with 1-4 equivalents of isocyanate having formula III . In formulae II and III R1,R2,R3,R4 and R5 are as mentioned above; interaction is carried out in 1,1-dichloroethane or in toluene at 35-60 C in the presence of CuCl and in the presence of phosphorous compound chosen of PPh3,P(pClPh)3,P(pMePh)3 and MePh2P. Compounds having formula I are suitable as antiprolactinic and antiparcinsonic agents. EFFECT: improved efficiency of the method.
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF ERGOLINE, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2131427C1 |
ANTHRACYCLINE GLYCOSIDE, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2118328C1 |
FLUORINATED DERIVATIVES OF 17β-SUBSTITUTED-4-AZA--5α-ANDROSTANE- -3-ONE, PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2125061C1 |
AZAANTRACYCLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2159245C2 |
POLYMERIC CONJUGATE, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149646C1 |
BIOLOGICALLY-ACTIVE POLYMER-BOUND ANTHRACYCLINES, INTERMEDIATES, PREPARATION METHODS, AND PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2145965C1 |
BINDING AGENT FOR BIOACTIVE PREPARATIONS, METHOD OF ITS SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS | 1991 |
|
RU2116087C1 |
DERIVATIVES OF ANTHRACYCLINONE AND THEIR USE IN AMYLOIDOSIS | 1995 |
|
RU2167661C2 |
DERIVATIVES OF 3'-AZIRIDINO-ANTHRACYCLINE, METHODS OF SYNTHESIS, PHARMACEUTICAL COMPOSITION | 1994 |
|
RU2149163C1 |
N-(HETERO)ARYL -N-(HETERO)TETRALINEALKYL PIPERAZINES AND METHOD OF PREPARING THEREOF | 1993 |
|
RU2115651C1 |
Authors
Dates
1998-08-27—Published
1993-02-15—Filed